| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |